Abstract: Disclosed in the present application are a locating method for an uplink time difference of arrival, and an apparatus thereof.

Abstract: Disclosed is a method of measuring a target on a substrate comprising: illuminating a target with measurement radiation comprising at least a first wavelength, collecting the resultant scattered radiation within a collection numerical aperture; and determining a parameter of interest from said scattered radiation. The target comprises a mediator periodic structure and at least a first target periodic structure each in a respective different layer on the substrate, wherein a pitch of at least the mediator periodic structure is below a single diffraction limit defined by the collection numerical aperture and a wavelength of said measurement radiation, such that said scattered radiation comprises double diffracted radiation, said double diffracted radiation comprising radiation having undergone two sequential same-order diffractions of opposite sign.

Abstract: A propylene polymer-based composite film, a preparation method therefor, and an application thereof are provided. The composite film contains at least two different layers: layer a and layer b layer. Layer a and layer b each contains at least one propylene polymer, and at least one of layer a and layer b contains a propylene impact copolymer. The propylene impact copolymer contains elastic moieties that form dispersed strip-like rubber phases in the composite film. The rubber phases are arranged parallel to each other. The average dimension of transverse axes of the rubber phases is 20-200 nm and the average of aspect ratios is 5-20. The composite film is can be used in the field of packaging materials, especially in battery packaging materials, electronic product packaging materials, or food packaging materials.

Abstract: Disclosed is a substrate and associated patterning device. The substrate comprises at least one target arrangement suitable for metrology of a lithographic process, the target arrangement comprising at least one pair of similar target regions which are arranged such that the target arrangement is, or at least the target regions for measurement in a single direction together are, centrosymmetric. A metrology method is also disclosed for measuring the substrate. A metrology method is also disclosed comprising which comprises measuring such a target arrangement and determining a value for a parameter of interest from the scattered radiation, while correcting for distortion of the metrology apparatus used.

Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease caused by a viral infection: (I) wherein R1, R2, R3, A, L, m, n, p and q are as defined herein.

Abstract: A method for preparing hexadecahydropyrene includes the step of carrying out the hydrogenation reaction to hydrocarbon oil containing pyrene compounds in the presence of a hydrogenation catalyst. The pyrene compounds are selected from at least one of pyrene and unsaturated hydrogenation products thereof. The hydrogenation catalyst contains a carrier and an active metal component loaded on the carrier. The active metal component is Pt and/or Pd and the carrier contains a small crystal size Y zeolite, alumina and amorphous silica-alumina. The small crystal size Y zeolite has an average grain diameter of 200-700 nm, a molar ratio of SiO2 to Al2O3 of 40-120, a relative crystallinity of ?95%, and a specific surface area of 900-1,200 m2/g. The pore volume of secondary pores in 1.7-10 nm diameter is more than 50% of the total pore volume.

Abstract: A method for preparing hexadecahydropyrene includes the step of carrying out the hydrogenation reaction to hydrocarbon oil containing pyrene compounds in the presence of a hydrogenation catalyst. The pyrene compounds are selected from at least one of pyrene and unsaturated hydrogenation products thereof. The hydrogenation catalyst contains a carrier and an active metal component loaded on the carrier. The active metal component is Pt and/or Pd and the carrier contains a small crystal size Y zeolite, alumina and amorphous silica-alumina. The small crystal size Y zeolite has an average grain diameter of 200-700 nm, a molar ratio of SiO2 to Al2O3 of 40-120, a relative crystallinity of ?95%, and a specific surface area of 900-1,200 m2/g. The pore volume of secondary pores in 1.7-10 nm diameter is more than 50% of the total pore volume.

Abstract: The invention relates to a flame-retardant thermoplastic material, comprising thermoplastic base resin, a flame retardant, and an optional antioxidant, wherein the flame retardant comprises a complex of phosphine oxide and a transition metal salt. The invention also relates to flame-retardant thermoplastic expanded beads. A foam molding prepared from the flame-retardant thermoplastic expanded beads has good flame-retardant and antistatic properties, has excellent mechanical properties and is widely used.

Abstract: The present invention refers to a flame retardant comprising a complex formed by phosphine oxide and transition metal salt, wherein has good flame retardant property. The present invention also refers to a composite flame retardant and flame retardant antistatic composition. The present invention also further refers to a flame resistant method, which adds the abovementioned flame retardant, composite flame retardant or flame retardant antistatic composition into the material, so that said material has flame retardance or flame retardance and antistatic, and has excellent mechanical properties.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: A polyethylene composition comprising an ethylene/?-olefin copolymerized linear low density polyethylene, wherein the polyethylene composition has a Mw of from 100,000 g/mol to 200,000 g/mol, a Mw/Mn of from 4.0 to 9.0, a Mz/Mw of from 4.0 to 7.0, and a Mz+1/Mw of from 4.5 to 13.5, is provided. A film formed of the polyethylene composition is also provided.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: The invention relates to a flame-retardant thermoplastic material, comprising thermoplastic base resin, a flame retardant, and an optional antioxidant, wherein the flame retardant comprises a complex of phosphine oxide and a transition metal salt. The invention also relates to flame-retardant thermoplastic expanded beads. A foam molding prepared from the flame-retardant thermoplastic expanded beads has good flame-retardant and antistatic properties, has excellent mechanical properties and is widely used.

Abstract: The present invention refers to a flame retardant comprising a complex formed by phosphine oxide and transition metal salt, wherein has good flame retardant property. The present invention also refers to a composite flame retardant and flame retardant antistatic composition, wherein composite flame retardant comprise the flame retardant and the inorganic flame retardant component as described above, which has an enhanced flame retardant effect; said flame retardant antistatic composition, comprising above described flame retardant or composite flame retardant and carbon nanofiber antistatic agent, wherein carbon nanofiber antistatic agent could have interaction with flame retardant, effectively reducing the amount of flame retardant, and the combination with the flame retardant without the adverse effect of each other which result in negative performance of each other, does not influence the subsequent foaming process and the foam structure and physical properties.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.

Abstract: A polyethylene composition comprising an ethylene/?-olefin copolymerized linear low density polyethylene, wherein the polyethylene composition has a Mw of from 100,000 g/mol to 200,000 g/mol, a Mw/Mn of from 4.0 to 9.0, a Mz/Mw of from 4.0 to 7.0, and a Mz+1/Mw of from 4.5 to 13.5, is provided. A film formed of the polyethylene composition is also provided.

Abstract: The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the variant polypeptides and proteins. Compositions and methods for treating muscle-wasting and other diseases and disorders are also provided.